Adding cognitive behavioral therapy to quetiapine in mood disorders is linked to reduced suicide risk and depressive symptoms ...

The findings one day could allow people with multiple mental health conditions to be treated with a single therapy, ...

Researchers from Hiroshima University in Japan and collaborating institutions have found that adults with asthma who ...

Johnson & Johnson today announced a new analysis of Phase 3 data which found CAPLYTA® (lumateperone), in combination with an antidepressant, showed significantly greater remission rates in adults with ...

Nitrous oxide, informally known as laughing gas, has shown rapid antidepressant effects in people with depression in a series ...

A sweeping new study of psychiatric and genetic records has the potential to change treatment for millions of psychiatric patients.

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

Rula reports that seasonal affective disorder (SAD) often co-occurs with substance use disorder, exacerbating symptoms in ...

Adding a daily fish oil supplement to psychotherapy showed no significant benefit over placebo for kids and teens with ...

The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to ...